MIF and Alzheimer disease: A recent study based on measurements of MIF levels in plasma and CSF in MCI or mild dementia (cognitive impairment, CI) patients established a significant role for MIF as biomarker in AD pathology for predicting cognitive failure in MCI and CI [88].